Interstitial lung disease in the patient who has connective tissue disease.
Interstitial lung disease is a common complication of many of the connective tissue diseases. Because the prognosis, degree of reversibility, and optimal therapy differs for each disease presentation, a thorough knowledge of the pulmonary presentations of each connective tissue disease is important. Additionally, the challenge of finding the patient who has occult connective tissue disease in an interstitial lung disease clinic is discussed.
Division of Pulmonary and Critical Care Medicine, Medical University of South Carolina, 96 Jonathan Lucas Street, 812 CSB, Charleston, SC 29425, USA. strangec@musc.edu
Charlie
C
Strange
Kristin B
KB
Highland
D001172:Arthritis, Rheumatoid / Q000453:epidemiology; D015897:Comorbidity; D003240:Connective Tissue Diseases / Q000175:diagnosis / Q000453:epidemiology*; D003520:Cyclophosphamide / Q000627:therapeutic use; D003882:Dermatomyositis / Q000453:epidemiology; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D017563:Lung Diseases, Interstitial / Q000188:drug therapy / Q000453:epidemiology*; D008180:Lupus Erythematosus, Systemic / Q000453:epidemiology; D010808:Physical Examination; D011014:Pneumonia / Q000453:epidemiology; D012595:Scleroderma, Systemic / Q000453:epidemiology
D007166:Immunosuppressive Agents; D003520:Cyclophosphamide